Abstract: The invention relates to a method for manufacturing a pharmaceutical form of oseltamivir phosphate, characterized by including the following steps: a) compacting followed by calibration of an oseltamivir phosphate powder, b) dry mixing with the known product excipients obtained from the previous step, following by calibration. Application to industrial production adapted to a crisis situation such as a pandemic.